LCAT and chronic kidney disease: In humans, urinary apoA-IV and LCAT are elevated in the early stages of kidney injury and have been considered markers of CKD, and increases in plasma apoA-IV when the glomerular filtration rate decreases may reflect reduced kidney clearance [67,194].